C.R. Bard gains clearance for biliary stent

January 19, 2000

Interventional equipment vendor C.R. Bard received 510(k) clearance this month from the Food and Drug Administration for its Memotherm Flexx biliary stent. The stent is used for treating malignant biliary obstructions, and will be marketed through Murray

Interventional equipment vendor C.R. Bard received 510(k) clearance this month from the Food and Drug Administration for its Memotherm Flexx biliary stent. The stent is used for treating malignant biliary obstructions, and will be marketed through Murray Hill, NJ-based Bard’s peripheral technologies division. The stent is available in diameters from 6 to 12 mm and lengths of 20 to 120 mm.